secwatch.observer — SEC 8-K summary
======================================

Issuer:     MEDIFAST INC (MED)
CIK:        0000910329
Form:       8-K
Filed at:   2025-08-04T23:59:59+00:00
Accession:  0000910329-25-000015
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medifast Q2 revenue falls 37.4% to $105.6M; active coaches down 33%; Q3 guidance weak
--------------------------------------------------------------------------------

- Revenue $105.6M, down 37.4% YoY; active OPTA VIA coaches 22,800 (-32.7% YoY); diluted EPS $0.22 (includes $2.0M net LifeMD gain).
- Net income $2.5M vs. loss $8.2M a year ago; operating loss improved to $1.1M from $7.9M.
- Cash and investments $162.7M, no debt; LifeMD stake sold during quarter.
- Q3 2025 guidance: revenue $70M-$90M; diluted EPS range ($0.60) to $0.00.
- Management cites ongoing client acquisition challenges and GLP-1 competition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/910329/000091032925000015/0000910329-25-000015-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/910329/000091032925000015/med-20250804.htm
  HTML page:      https://secwatch.observer/filing/0000910329-25-000015

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer